https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia" https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48375 Wed 15 Mar 2023 13:47:42 AEDT ]]> Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30888 Thu 09 Dec 2021 11:03:11 AEDT ]]> Loss of expression of both miR-15/16 loci in CML transition to blast crisis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49365 Fri 12 May 2023 12:42:20 AEST ]]>